Franklin Lakes-based BD, one of the largest global medical technology companies in the world, works to advance the quality of health care by improving medical discovery, diagnostics and the safe delivery of care. Led by President and CEO Tom Polen, BD is now one of the many New Jersey companies leading the global efforts to battle the COVID-19 pandemic.
Polen met early on in the pandemic with President Donald Trump, administration officials and other business leaders who have been involved in the effort to expand access to COVID-19 testing and test development stating the company’s support of the U.S. effort to combat coronavirus. “[W]e are working around the clock internally and with external partners to increase the coronavirus diagnostic capacity in the U.S by ramping up production of our sample collection tools and increasing access to our automated molecular platform for in vitro diagnostics,” Polen said at the time.
BD recently garnered a $24 million investment from the federal government to scale up U.S. manufacturing production of its COVID-19 rapid diagnosis testing kits.
In November BD received an order from the Dutch Ministry of Health for 9.2 million of its rapid COVID-19 tests for use on the BD Veritor Plus System, and most recently announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems across its six global manufacturing locations and add a new manufacturing facility in Europe.